NCT00174369 - MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

PD-0325901

15 mg BID

Trial Locations (14)

Pfizer Investigational Site, New York

Pfizer Investigational Site, Philadelphia

Pfizer Investigational Site, Tampa

Pfizer Investigational Site, Detroit

Pfizer Investigational Site, Farmington Hills

Pfizer Investigational Site, Robbinsdale

Pfizer Investigational Site, Fridley

Pfizer Investigational Site, Coon Rapids

Pfizer Investigational Site, La Jolla

Pfizer Investigational Site, La Jolla

Pfizer Investigational Site, San Diego

Pfizer Investigational Site, San Mateo

Pfizer Investigational Site, Greenbrae

Pfizer Investigational Site, Ann Arbor